Showing 8,561 - 8,580 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (larger decrease)) ))', query time: 2.20s Refine Results
  1. 8561

    2-DG blocks HHV-6-mediated glycolytic activation. by Zhisheng Wu (1540864)

    Published 2020
    “…<b>(A)</b> 2-DG treatment significantly decreased glucose uptake in HHV-6-infected cells. …”
  2. 8562
  3. 8563
  4. 8564
  5. 8565
  6. 8566
  7. 8567
  8. 8568
  9. 8569
  10. 8570
  11. 8571
  12. 8572
  13. 8573
  14. 8574
  15. 8575
  16. 8576
  17. 8577

    A 92-year-old female with 80% stenosis of left internal carotid artery received carotid stenting. by Han-Jui Lee (803878)

    Published 2017
    “…<p>(A) Pre-stenting MR perfusion showed decreased cerebral blood flow in the right hemisphere compared to the left hemisphere. …”
  18. 8578

    Fig 9 - by Mamatha Garige (10719830)

    Published 2021
    “…<i>discoideum</i>. (A) <i>D</i>. <i>discoideum</i> cell proliferation was decreased by 60% at the end of 72 hours (doxycycline-induced) <i>gstA2</i>-knockdown cells, whereas (B) overexpression of DdGSTA2 did not significantly affect the proliferation of cells. …”
  19. 8579

    Protein abundance changes with stage in the glycolysis pathway. by Benjamin A. Neely (625157)

    Published 2016
    “…Levels of two proteins, PFKP and PKM, were confirmed using IHC staining of stage I ccRCC tissue (other stages were not evaluated by IHC). A representative IHC image is shown for PFKP and PKM along with average staining intensity (H value) ± standard error of a stage I ccRCC TMA. …”
  20. 8580

    A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma by Fernando Alegre (6166193)

    Published 2018
    “…Additionally, our subcutaneous OSA xenograft model demonstrated <i>in vivo</i> tumor growth delay, increased necrosis and apoptosis by tRNA/miR-34a, and decreased cellular proliferation ability. …”